These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11374329)

  • 21. Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs.
    Bowen AJ
    J Int Med Res; 1978; 6(4):337-42. PubMed ID: 28989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sleep spindle and delta changes during chronic use of a short-acting and a long-acting benzodiazepine hypnotic.
    Johnson LC; Spinweber CL; Seidel WF; Dement WC
    Electroencephalogr Clin Neurophysiol; 1983 Jun; 55(6):662-7. PubMed ID: 6189696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of preference for nightly triazolam versus placebo in moderate social alcohol drinkers.
    Mintzer MZ; Allen RP; Griffiths RR
    J Psychopharmacol; 2001 Mar; 15(1):3-8. PubMed ID: 11277606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients.
    Lomen P; Linet OI
    J Int Med Res; 1976; 4(1):55-8. PubMed ID: 16792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1992; 108(1-2):67-71. PubMed ID: 1410148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can a rapidly-eliminated hypnotic cause daytime anxiety?
    Adam K; Oswald I
    Pharmacopsychiatry; 1989 May; 22(3):115-9. PubMed ID: 2748714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reinforcing effects of triazolam in sedative abusers: correlation of drug liking and self-administration measures.
    Roache JD; Meisch RA; Henningfield JE; Jaffe JH; Klein S; Sampson A
    Pharmacol Biochem Behav; 1995 Feb; 50(2):171-9. PubMed ID: 7740055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
    Bliwise DL; Seidel WF; Cohen SA; Bliwise NG; Dement WC
    J Clin Psychiatry; 1988 Sep; 49(9):349-55. PubMed ID: 3047100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a reduced triazolam dose in elderly insomniacs.
    Roehrs T; Zorick F; Wittig R; Roth T
    Neurobiol Aging; 1985; 6(4):293-6. PubMed ID: 4088425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midazolam and triazolam in out-patients: a double-blind comparison of hypnotic efficacy.
    Costa E Silva JA; Acioli A; Naylor C; Jones Da Silva C; Ferreira I
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):179S-183S. PubMed ID: 6138075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
    Fleming JA; McClure DJ; Mayes C; Phillips R; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():29-37. PubMed ID: 2201728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of triazolam and methyprylon as a hypnotic in insomniacs.
    Linet OI; Rudzik AD
    Psychopharmacol Commun; 1975; 1(5):473-80. PubMed ID: 7002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of short-acting hypnotics.
    Mendelson WB; Jain B
    Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical comparison of triazolam with placebo and with secobarbital in insomniac patients.
    Okawa KK; Allens GS
    J Int Med Res; 1978; 6(4):343-7. PubMed ID: 28990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia.
    Fabre LF; Brachfeld J; Meyer LR; Slowe IA; Calvo R; Metzler C
    J Clin Psychiatry; 1978 Aug; 39(8):679-82. PubMed ID: 28313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of a single night's dosing with triazolam on sleep the following night.
    Mamelak M; Csima A; Price V
    J Clin Pharmacol; 1990 Jun; 30(6):549-55. PubMed ID: 2355105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bright light treatment for night-time insomnia and daytime sleepiness in elderly people: comparison with a short-acting hypnotic.
    Usui A; Ishizuka Y; Matsushita Y; Fukuzawa H; Kanba S
    Psychiatry Clin Neurosci; 2000 Jun; 54(3):374-6. PubMed ID: 11186120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose determinants of rebound insomnia.
    Roehrs TA; Zorick FJ; Wittig RM; Roth T
    Br J Clin Pharmacol; 1986 Aug; 22(2):143-7. PubMed ID: 3530302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The need for flexibility in dosing of hypnotic agents.
    Doghramji K
    Sleep; 2000 Feb; 23 Suppl 1():S16-20; discussion S21-2. PubMed ID: 10755804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.